EPISODE · Apr 8, 2026 · 17 MIN
Body Composition & Risk in Psoriatic Disease
from Inside GRAPPA
In this episode, host Dr. Mio Nakamura (University of Michigan) speaks with Dr. Lyn Ferguson (University of Glasgow) about her study on how body composition (not just weight) impacts psoriatic disease and cardiometabolic risk. This study was supported by a GRAPPA Pilot Research Grant.HighlightsObesity is strongly linked to worse psoriasis and psoriatic arthritis outcomesVisceral fat, liver fat, and muscle fat are more important than BMI alonePatients with psoriatic disease show:Higher visceral and ectopic fatLower muscle volumeAdverse muscle composition (low muscle + high fat) is a key risk marker:~3× higher risk of type 2 diabetes2× higher risk of heart diseaseMay also help predict future psoriasis riskConnectStay up to date with the latest in psoriatic disease research and GRAPPA initiatives: https://www.grappanetwork.org Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
In this episode, host Dr. Mio Nakamura (University of Michigan) speaks with Dr. Lyn Ferguson (University of Glasgow) about her study on how body composition (not just weight) impacts psoriatic disease and cardiometabolic risk. This study was supported by a GRAPPA Pilot Research Grant.HighlightsObesity is strongly linked to worse psoriasis and psoriatic arthritis outcomesVisceral fat, liver fat, and muscle fat are more important than BMI alonePatients with psoriatic disease show:Higher visceral and ectopic fatLower muscle volumeAdverse muscle composition (low muscle + high fat) is a key risk marker:~3× higher risk of type 2 diabetes2× higher risk of heart diseaseMay also help predict future psoriasis riskConnectStay up to date with the latest in psoriatic disease research and GRAPPA initiatives: https://www.grappanetwork.org Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Body Composition & Risk in Psoriatic Disease
No transcript for this episode yet
Similar Episodes
Apr 29, 2026 ·48m
Apr 29, 2026 ·106m
Apr 29, 2026 ·55m
Apr 29, 2026 ·74m